Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- MeSH Terms
- Immunotherapy (E02.095.465.425); Neoplasms (C04)
- Guideline Contact
- [email protected]
- Publication Date
- 14-Feb-18
- Publication Scope
- management
- Countries of Application
- United States
- Guideline Publication Status
- Under Review
- Languages
- English
- Authors
- ASCO (US)
- Publication Year
- 2018